Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$6.45 USD
+0.05 (0.78%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $6.44 -0.01 (-0.16%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.45 USD
+0.05 (0.78%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $6.44 -0.01 (-0.16%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Zacks News
Has Nu Skin Enterprises (NUS) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Philip Morris Extends Deal With KT&G, RRPs Expansion on Track
by Zacks Equity Research
Philip Morris (PM) will start commercialization of KT&G's smoke-free alternatives outside South Korea, beginning with Russia.
Zacks.com featured highlights include: Medifast, ANGI Homeservices, Expeditors International of Washington and Nu Skin
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, ANGI Homeservices, Expeditors International of Washington and Nu Skin
Philip Morris Gains on RRPs & Pricing Amid Low Cigarette Sales
by Zacks Equity Research
Philip Morris' (PM) cigarette sales have been dismal due to lower demand and pandemic-led restrictions. Nevertheless, RRPs are depicting continued rise.
4 Top-Ranked Liquid Bets to Build a Successful Portfolio
by Radhika Pujara
Here are four top-ranked liquid stocks, including Medifast (MED) that investors can add to their portfolio for fat returns.
Cleaning Product Demand Aids P&G's Growth: Will it Persist?
by Zacks Equity Research
Procter & Gamble (PG) is one of the beneficiaries of the recent spike in demand for cleaning and disinfecting products amid the pandemic. However, currency headwinds continue to play spoilsport.
Inter Parfums (IPAR) Posts Narrower-Than-Expected Q2 Loss
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2020 results reflect lower sales thanks to coronavirus-induced retail outlet closures. Also, sales declined across all regions and brands.
6 Stocks Trading Near 52-Week Highs That Can Rally Further
by Anirudha Bhagat
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have higher chances of carrying the momentum forward.
Are Investors Undervaluing Nu Skin Enterprises (NUS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Nu Skin's (NUS) Q2 Earnings Beat Estimates, Sales Decline Y/Y
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2020 results reflect lower earnings and sales. Nevertheless, management raises 2020 view on better than expected year-to-date performance.
Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 20.90% and 1.05%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Flowers Foods (FLO) in Q2 Earnings?
by Zacks Equity Research
Strength in branded retail with Nature's Own, Canyon Bakehouse, Dave's Killer Bread and Wonder brands might reflect on Flowers Foods' (FLO) Q2 results.
Here's How Post Holdings (POST) Looks Ahead of Q3 Earnings
by Zacks Equity Research
Impacts of higher costs as well as lower demand in foodservice business are likely to get reflected in Post Holdings' (POST) third-quarter fiscal 2020 performance.
What's in the Cards for Medifast (MED) This Earnings Season?
by Zacks Equity Research
Strength in OPTAVIA brand is likely to get reflected in Medifast's (MED) second-quarter 2020 performance. However, rising SG&A expenses is a concern.
Clorox (CLX) Beats Q4 Earnings & Sales Estimates, Stock Down
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2020 results reflect gains from the robust demand for disinfecting and cleaning products due to the coronavirus outbreak, and broad-based growth at all segments.
The Zacks Analyst Blog Highlights: BGS, MNST, MED, NUS and FLO
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BGS, MNST, MED, NUS and FLO
The Zacks Analyst Blog Highlights: Noble Energy, TopBuild, Nu Skin, Bonanza Creek and Ollie's Bargain
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Noble Energy, TopBuild, Nu Skin, Bonanza Creek and Ollie's Bargain
The Zacks Analyst Blog Highlights: Meritage Homes, PulteGroup, Silgan, D.R. Horton and Nu Skin
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Meritage Homes, PulteGroup, Silgan, D.R. Horton and Nu Skin
5 Consumer Staples Stocks to Beat on Earnings Amid Coronavirus
by Zacks Equity Research
Amid coronavirus crisis, players in the Consumer Staples sector are gaining from rising demand on stockpiling. We bring five stocks with earnings beat potential.
Here's How Beyond Meat (BYND) is Placed Ahead of Q2 Earnings
by Zacks Equity Research
Beyond Meat's (BYND) second-quarter results are likely to reflect strength in the retail business due to higher at-home consumption, while the foodservice business may remain under pressure.
Service Corporation (SCI) Q2 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2020 results reflect higher earnings and sales, courtesy of increased funeral services performed amid the pandemic and solid cost control.
Top 5 Consumer Staple Stocks Ahead of Q2 Earnings Results
by Nalak Das
The consumer staples sector has so far reported relatively better results despite the decline of overall sector's earnings year over year.
Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: NUS, AN, ROK, CSCO and FLT
by Zacks Equity Research
Zacks.com featured highlights include: NUS, AN, ROK, CSCO and FLT